BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Lejman M, Kuśmierczuk K, Bednarz K, Ostapińska K, Zawitkowska J. Targeted Therapy in the Treatment of Pediatric Acute Lymphoblastic Leukemia-Therapy and Toxicity Mechanisms. Int J Mol Sci 2021;22:9827. [PMID: 34575992 DOI: 10.3390/ijms22189827] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 2.0] [Reference Citation Analysis]
Number Citing Articles
1 Bernsen EC, Hogenes VJ, Nuijen B, Hanff LM, Huitema ADR, Diekstra MHM. Practical Recommendations for the Manipulation of Kinase Inhibitor Formulations to Age-Appropriate Dosage Forms. Pharmaceutics 2022;14. [PMID: 36559327 DOI: 10.3390/pharmaceutics14122834] [Reference Citation Analysis]
2 Kyriakidis I, Mantadakis E, Stiakaki E, Groll AH, Tragiannidis A. Infectious Complications of Targeted Therapies in Children with Leukemias and Lymphomas. Cancers (Basel) 2022;14:5022. [PMID: 36291806 DOI: 10.3390/cancers14205022] [Reference Citation Analysis]
3 He F, Yi L, Lai C. Fut7 Promotes Adhesion and Invasion of Acute Lymphoblastic Leukemia Cells through the Integrin/Fak/Akt Pathway. Evid Based Complement Alternat Med 2022;2022:1864116. [PMID: 35795270 DOI: 10.1155/2022/1864116] [Reference Citation Analysis]
4 Mengxuan S, Fen Z, Runming J. Novel Treatments for Pediatric Relapsed or Refractory Acute B-Cell Lineage Lymphoblastic Leukemia: Precision Medicine Era. Front Pediatr 2022;10:923419. [DOI: 10.3389/fped.2022.923419] [Reference Citation Analysis]
5 Tian S, Guo Y, Fu J, Li Z, Li J, Tian X, Hussein AF. Prognostic Value of Immunotyping Combined with Targeted Therapy in Patients with Non-Small-Cell Lung Cancer and Establishment of Nomogram Model. Computational and Mathematical Methods in Medicine 2022;2022:1-9. [DOI: 10.1155/2022/3049619] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
6 Pawinska-wasikowska K, Wieczorek A, Balwierz W, Bukowska-strakova K, Surman M, Skoczen S. Blinatumomab as a Bridge Therapy for Hematopoietic Stem Cell Transplantation in Pediatric Refractory/Relapsed Acute Lymphoblastic Leukemia. Cancers 2022;14:458. [DOI: 10.3390/cancers14020458] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]